Center For Scientific Review; Notice of Closed Meetings, 26066-26067 [2018-12016]
Download as PDF
26066
Federal Register / Vol. 83, No. 108 / Tuesday, June 5, 2018 / Notices
Notice is
hereby given that the Office of Research
Integrity (ORI) has taken final action in
the following case:
Shiladitya Sen, The Ohio State
University: Based on the report of an
investigation conducted by OSU and
analysis conducted by ORI in its
oversight review, ORI found that Mr.
Shiladitya Sen, former graduate student,
OSU, engaged in research misconduct in
research supported by NIGMS, NIH,
grant R01 GM083114.
ORI found that Respondent engaged
in research misconduct by knowingly
and intentionally falsifying and/or
fabricating data reported in the
following published paper, his Ph.D.
thesis, a poster presentation, and his
mentor’s grant applications submitted to
NIGMS, NIH:
• PNAS 110(11):4261–4266, 2013
(hereafter referred to as ‘‘PNAS
2013’’); retracted in: PNAS
114(37):E7855, 2017 Sep
• Sen, S. ‘‘Engineering Proteins for
Enhanced Stability using HighThroughput and Combinatorial
Methods.’’ OSU Doctoral Dissertation,
2013 (hereafter referred to as ‘‘thesis’’)
• poster presented at the Annual
Symposium of the Protein Society in
2012 (hereafter referred to as ‘‘Poster
2012’’)
• R01 GM083114 and R01 GM083114–
A1
ORI found that Respondent
knowingly and intentionally falsified
and/or fabricated gene sequencing and
high throughput thermal scanning
(HTTS) data for sequence-stability
relationship of Rop protein variants in
nineteen (19) figures, ten (10) tables,
and related text included in a poster
presentation, his Ph.D. thesis, and two
(2) NIH grant applications.
Specifically, Respondent knowingly
and intentionally falsified and/or
fabricated:
• Unique sequences and stability data
for 1017 active Rop variants in Table
3.1 and provided additional analyses
purportedly from those active Rop
variants in Table 3.2 and Figures 3.3,
3.4, 3.5, 3.6, 3.7, 3.8, and 3.9 in his
thesis and in Figures 6, 7, 17, and 20
in two (2) grant applications
• unique sequences and stability data
for active Rop loop variants from four
separate mutant libraries, X4, LX4, X4I, LX4-I in Tables 5.2, 5.3, 5.4, and 5.5,
respectively, and presented additional
analyses purportedly from those
active Rop loop variants in Figures
5.3, 5.4, 5.5, 5.6, and 5.9 and Table 5.1
in his thesis and in Figure 6 in two
(2) grant applications
• figures entitled ‘‘analysis of more than
1000 active (folded) core variants,’’
amozie on DSK3GDR082PROD with NOTICES1
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
20:19 Jun 04, 2018
Jkt 241001
‘‘Loop Library: How does loop affect
stability?’’ and ‘‘Detailed
characterization of loop variants’’ in
Poster 2012
• list of oligonucleotides included in
Tables 9.2, 9.3, and 9.4 in his thesis
ORI also found that Respondent
knowingly and intentionally falsified
and/or fabricated HTTS data for
thermodynamic effects of somatic
mutation in antibodies 93F3 and OKT3
in ten (10) figures, two (2) tables, and
related text included in PNAS 2013 and
his thesis.
Specifically, Respondent knowingly
and intentionally falsified and/or
fabricated HTTS data:
• In Figures 6.2A, 6.2C, 6.3, and 6.6 and
Tables 6.2 and 6.3 in his thesis
• also included as Figures 2A, 2C, S2,
and S5 and Tables S3 and S4 in PNAS
2013
Mr. Sen entered into a Voluntary
Exclusion Agreement and voluntarily
agreed for a period of three (3) years,
beginning on May 16, 2018:
(1) To exclude himself voluntarily
from any contracting or subcontracting
with any agency of the United States
Government and from eligibility for or
involvement in nonprocurement
programs of the United States
Government referred to as ‘‘covered
transactions’’ pursuant to HHS’
Implementation (2 CFR part 376) of
OMB Guidelines to Agencies on
Governmentwide Debarment and
Suspension, 2 CFR part 180 (collectively
the ‘‘Debarment Regulations’’);
(2) to exclude himself voluntarily
from serving in any advisory capacity to
PHS including, but not limited to,
service on any PHS advisory committee,
board, and/or peer review committee, or
as a consultant.
Wanda K. Jones,
Interim Director, Office of Research Integrity.
[FR Doc. 2018–12047 Filed 6–4–18; 8:45 am]
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Psychosocial Risk and Disease Prevention.
Date: June 12, 2018.
Time: 8:00 a.m. to 11:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: Mayflower Park Hotel, 405 Olive
Way, Seattle, WA 98101.
Contact Person: Weijia Ni, Ph.D., Chief/
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3100,
MSC 7808, Bethesda, MD 20892, (301) 594–
3292, niw@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Risk
Prevention and Health Behavior AREA
Review.
Date: June 19, 2018.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: John H Newman, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3222,
MSC 7808, Bethesda, MD 20892, (301) 435–
0628, newmanjh@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Atherosclerosis, Inflammation, Molecular
and Cellular Hematology.
Date: June 25, 2018.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Katherine M Malinda,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4140,
MSC 7814, Bethesda, MD 20892, 301–435–
0912, Katherine_Malinda@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Integrative Neuroscience.
Date: June 25, 2018.
Time: 12:30 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Ying-Yee Kong, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5185,
Bethesda, MD 20892, ying-yee.kong@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
E:\FR\FM\05JNN1.SGM
05JNN1
amozie on DSK3GDR082PROD with NOTICES1
Federal Register / Vol. 83, No. 108 / Tuesday, June 5, 2018 / Notices
Developing and Testing Interventions for
Health-Enhancing Physical Activity.
Date: June 26, 2018.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Weijia Ni, Ph.D., Chief/
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3100,
MSC 7808, Bethesda, MD 20892, 301–594–
3292, niw@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Surgical Sciences, Biomedical
Imaging and Bioengineering.
Date: June 27, 2018.
Time: 10:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Guo Feng Xu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5122,
MSC 7854, Bethesda, MD 20892, 301–237–
9870, xuguofen@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Interdisciplinary Molecular Sciences
Training Member Conflict.
Date: June 27, 2018.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Alexander Gubin, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6046B,
MSC 7892, Bethesda, MD 20892, 301–408–
9655, gubina@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Nephrology.
Date: June 27, 2018.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Jonathan K. Ivins, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2190,
MSC 7850, Bethesda, MD 20892, (301) 594–
1245, ivinsj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Acute Brain Injury and Recovery.
Date: June 27, 2018.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
VerDate Sep<11>2014
20:19 Jun 04, 2018
Jkt 241001
Contact Person: Alexander Yakovlev,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5206,
MSC 7846, Bethesda, MD 20892–7846, 301–
435–1254, yakovleva@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Pain and Somatosensory Topics.
Date: June 27, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Jasenka Borzan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive Room 4214
MSC 7814, Bethesda, MD 20892–7814, 301–
435–1787, borzanj@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 31, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–12016 Filed 6–4–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group; Neurobiology of
Learning and Memory Study Section.
Date: June 26, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Washington Plaza Hotel, 10 Thomas
Circle NW, Washington, DC 20005.
Contact Person: Wei-Qin Zhao, Ph.D.,
Scientific Review Officer, Center for
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
26067
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5181,
MSC 7846, Bethesda, MD 20892–7846, 301–
827–7238, zhaow@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Endocrinology, Metabolism,
Nutrition and Reproductive Sciences.
Date: June 27–28, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Clara M. Cheng, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6170,
MSC 7892, Bethesda, MD 20892, 301–435–
1041, chengc@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Aging and Development, Auditory,
Vision and Low Vision Technologies.
Date: June 28–29, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Mayflower Hotel, DC, 1127
Connecticut Ave. NW, Washington, DC
20036.
Contact Person: Paek-Gyu Lee, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4201,
MSC 7812, Bethesda, MD 20892 (301) 613–
2064, leepg@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR:
Selected Topics in Transfusion Medicine.
Date: June 28–29, 2018.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Ai-Ping Zou, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118,
MSC 7814, Bethesda, MD 20892, 301–408–
9497, zouai@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Gene Regulatory Networks and
Interactomes.
Date: June 28, 2018.
Time: 1:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Methode Bacanamwo,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2200,
Bethesda, MD 20892, 301–827–7088,
methode.bacanamwo@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics on Metabolism and Disease.
Date: June 28, 2018.
E:\FR\FM\05JNN1.SGM
05JNN1
Agencies
[Federal Register Volume 83, Number 108 (Tuesday, June 5, 2018)]
[Notices]
[Pages 26066-26067]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-12016]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Psychosocial Risk and Disease Prevention.
Date: June 12, 2018.
Time: 8:00 a.m. to 11:00 a.m.
Agenda: To review and evaluate grant applications.
Place: Mayflower Park Hotel, 405 Olive Way, Seattle, WA 98101.
Contact Person: Weijia Ni, Ph.D., Chief/Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3100, MSC 7808, Bethesda, MD
20892, (301) 594-3292, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Risk Prevention and Health Behavior AREA Review.
Date: June 19, 2018.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John H Newman, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3222, MSC 7808, Bethesda, MD 20892, (301) 435-
0628, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Atherosclerosis, Inflammation, Molecular and Cellular
Hematology.
Date: June 25, 2018.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Katherine M Malinda, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4140, MSC 7814, Bethesda, MD
20892, 301-435-0912, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Integrative Neuroscience.
Date: June 25, 2018.
Time: 12:30 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ying-Yee Kong, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5185, Bethesda, MD 20892, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel:
[[Page 26067]]
Developing and Testing Interventions for Health-Enhancing Physical
Activity.
Date: June 26, 2018.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Weijia Ni, Ph.D., Chief/Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3100, MSC 7808, Bethesda, MD
20892, 301-594-3292, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflicts: Surgical Sciences, Biomedical Imaging and
Bioengineering.
Date: June 27, 2018.
Time: 10:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Guo Feng Xu, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5122, MSC 7854, Bethesda, MD 20892, 301-237-
9870, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Interdisciplinary Molecular Sciences Training Member
Conflict.
Date: June 27, 2018.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Alexander Gubin, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6046B, MSC 7892, Bethesda, MD
20892, 301-408-9655, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Topics in Nephrology.
Date: June 27, 2018.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Jonathan K. Ivins, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2190, MSC 7850, Bethesda, MD
20892, (301) 594-1245, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Acute Brain Injury and Recovery.
Date: June 27, 2018.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Alexander Yakovlev, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5206, MSC 7846, Bethesda, MD
20892-7846, 301-435-1254, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Pain and Somatosensory Topics.
Date: June 27, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jasenka Borzan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive Room 4214 MSC 7814, Bethesda, MD 20892-
7814, 301-435-1787, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: May 31, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-12016 Filed 6-4-18; 8:45 am]
BILLING CODE 4140-01-P